A new analysis of 10 studies looked at whether trolamine, a skin cream, helps breast cancer patients who get radiation therapy. Radiation can cause skin problems, from mild redness to painful peeling. The review included 980 patients.
The results showed that using trolamine increased the chance of having only mild skin reactions (grade 0 or 1). In fact, patients using the cream were almost twice as likely to have no or mild skin issues compared to those who didn't use it.
More importantly, trolamine reduced the risk of more serious skin problems. The chance of having grade 2 skin reactions (like moderate redness and swelling) was about half. The risk of grade 3 or higher reactions (severe peeling or sores) was even lower, dropping by about 63%.
However, the quality of evidence for some of these findings was rated as low, meaning we can't be completely sure of the exact benefit. The evidence for preventing the most severe reactions was rated as moderate.
Overall, trolamine appears to be a helpful option for protecting the skin during radiation therapy for breast cancer. Patients should talk to their doctors about whether this cream is right for them.
